BMY Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Portfolio Strength ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips QVCGP Q3 2025 Earnings Significant Loss Per Common Share Reported Preferred Stock Unchanged MYSZ Q4 2025 Earnings Significant EPS Miss Amid Revenue Uncertainty Ames National Corporation ATLO Q1 2026 Earnings Solid EPS Beat Amid Stable Operations NLY Q1 2026 Earnings Slight EPS Beat Amid Mortgage Market Shifts